Category: Postdoc Job

University of Kentucky – T32 Post-Doctoral Fellow

HealthCare Markey Cancer Center logo

Location: Lexington, KY
Application Deadline: 5/26/26

From Bench to Breakthrough: Advancing the Next Generation of Cancer Scientist

Join the University of Kentucky’s Prestigious T32: Interdisciplinary Research Training Program in Cancer Biology Are you ready to push the boundaries of cancer science and make a lasting impact on human health? The University of Kentucky’s Cancer Biology T32 Program (T32 CA165990)—funded by the National Cancer Institute—is a premier interdisciplinary training initiative designed to empower the next generation of cancer researchers.

Led by Drs. Kathleen O’Connor, B. Mark Evers, and Christine Brainson, at the University of Kentucky Markey Cancer Center, this program offers a transformative experience for post-doctoral fellows who are passionate about advancing cancer prevention, diagnosis, and treatment.
This multi-disciplinary program focuses on training post-doctoral fellows in cancer biology so that they can effectively decipher important research questions associated with human cancer. The program integrates the already established and successful programs in Signal Transduction and Mechanisms of Cancer Cell Survival, Cancer Progression and Metastasis, Tumor Microenvironment, and Oxidative Stress and DNA Damage into one cohesive program. Trainees will receive both didactic and non-didactic instruction, including laboratory-based basic science research, exposure to cutting edge clinical applications, and career development opportunities.

A unique feature of this program is the interdisciplinary training opportunity that will emphasize bench to bedside research topics to provide a bridge between the fundamental biology of cancer and clinical cancer. Our goal is to develop a cadre of future scientists who can become leaders in integrative team approaches to better understand the complex issue of cancer as it relates to prevention and treatment strategies.

Why Choose This Program?
This is not just training—It is a launchpad for your career in cancer biology. You will gain:
• Comprehensive, hands-on training: in cutting-edge cancer research techniques
• Access to world-class mentors: across diverse disciplines in cancer research
• Exposure to clinical environments: through shadowing and physician-scientist mentorship
• Career development support: including seminars, symposia, and networking opportunities
• Funding: for travel, health insurance, and tuition support

Research Focus Areas
Trainees dive deep into high-impact topics, including:
• Signal Transduction & Cancer Cell Survival
• Tumor Microenvironment & Metastasis
• Cancer Epigenetics & Stem Cells
• DNA Damage & Repair
• Immunotherapy & Cancer Metabolomics
• Oxidative Stress & Cancer Progression

This program bridges bench-to-bedside research, giving you the tools to translate discoveries into clinical breakthroughs.

Mentorship That Matters
Work alongside leading experts from departments such as Biochemistry, Toxicology and Cancer Biology, Surgery, Pharmacology and Nutritional Sciences, and Microbiology, Immunology and Molecular Genetics. Additionally, mentees may choose mentors who are not included on the T32 but work on cancer-related topics at the University of Kentucky.

Eligibility & Requirements

All Applicants:
• Must be U.S. citizens or permanent residents
• Must have interest in pursuing a career in cancer-related field
• Must have completed the foundation courses in graduate level: Genetics, Biochemistry, Immunology, Pharmacology, Physiology, Cell Biology, Molecular Biology, and Biostatistics
Number of Positions Currently Available:
• 2- Post-Doctoral Fellows

Program requirements:
• Trainees are expected to complete an ethics course as well as a Cancer Biology and Therapy course, which emphasizes cancer in the context of human disease.
• Trainees will participate in the Markey Cancer Center weekly seminar series as well as participate in a variety of seminars, workshops and symposia at UK over the course of their training.
• Each trainee is required to shadow a clinician and include one physician-scientist on their mentoring committee.

Stipend & Support
Stipends are based on NIH guidelines and include:
• Health insurance
• Tuition coverage
• Travel funding for conferences and training supplies

Ready to Apply?
Submit your application materials to Dr. Katelyn Jones (katelyn.jones13@uky.edu). The position(s) will remain open until the best candidate is recruited; applications will be reviewed according to the order in which they are received. Top candidates may be asked to participate in an interview with the Executive Steering Committee before final decisions are made.
1) Applications should include the following components: A 1–2-page letter detailing your research experience, commitment to cancer research or cancer biology, and a brief proposal.
The applicant should indicate how their thesis research and/or career will benefit from cross-disciplinary training in oncologic research.
2) Curriculum Vitae and academic transcripts
3) Mentor’s letter of support outlining your research plan
4) Contact info for two additional references

The Executive Steering Committee will select the top candidates and interview them before making a final decision.

Questions?
Reach out to Dr. Katelyn Jones for more information kmjo277@uky.edu

FLYER

Read More

The Philadelphia Postdoc Preview

Location: Philadelphia, Pennsylvania
Date: Tuesday, February 10, 2026

Join us to learn about postdoctoral training opportunities in Philadelphia!
The Philadelphia Postdoc Preview event is a collaborative effort to raise awareness about the numerous postdoctoral training opportunities at 8 research institutions across Philadelphia including The Children’s Hospital of Philadelphia, The Drexel University College of Medicine, Fox Chase Cancer Center – Temple Health, Lewis Katz School of Medicine – Temple Health, Monell Chemical Senses Center, Thomas Jefferson University, University of Pennsylvania Biomedical Postdoctoral Programs, and The Wistar Institute.

The next Philadelphia Postdoc Preview will be held on Tuesday February 10, 2026. During the Preview, participants will learn about:
-The various Postdoctoral training programs at participating research institutions
-What to consider when choosing where to train
-How to apply to a postdoc
-What it is like to live and work in Philadelphia?

The goal of the Preview event is to raise awareness of the robust training opportunities in the Philadelphia area. Whether you are interested in studying basic, translational, or clinical research in human or model systems, Philadelphia has lots of options for those interested in expanding their research expertise, developing professional skills needed in today’s job market, and growing a network of engaged and successful colleagues.

The target audience for the Preview event includes senior Ph.D. students (who have passed their qualifying exam or are post-candidacy by the time of the event), recent Ph.D. graduates, or early-career postdoc scholars in science, technology, engineering, math, and medical fields. Postdoctoral opportunities at participating institutions include basic, translational, and clinical research. Information on clinical residencies and fellowships will NOT be presented.

There is no citizenship requirement to register. We are seeking domestic and international candidates alike!

For more information, go to: https://www.philadelphiapostdoc.com/


Read More

Fox Chase Cancer Center – Postdoctoral Fellow Molecular Hematology

Location: Philadelphia, Pennsylvania

Application Deadline: 1/31/26

The Hanzhi Luo Laboratory at the Fox Chase Cancer Center, Philadelphia is hiring highly ambitious and self-motivated Postdoctoral Fellows in Molecular Hematology. Applicants with a PhD and/or MD degree and the ability to work in a competitive environment should apply. Expertise in hematopoietic stem cell, murine hematopoietic leukemia, molecular biology, computation biology and RNA-related assays is preferred.
The Luo laboratory uses state-of-the-art technologies and collaborations with leading scientist and clinicians to address the following areas:

  1. Molecular basis of stem cell fate choices.
  2. Identification and characterization of RNA regulatory mechanisms in normal physiology and diseases.
  3. Molecular basis of cancer-associated RNA modifications.
    Some example publications addressing these areas of interest are: Luo et al. (2023) Cell Stem Cell; Cheng et al. (2019) Cell reports; Additional details regarding the laboratory research can be found at www.luolab-fccc.com

FAQS:

  1. Full-time or part-time? Full time
  2. On-site, Hybrid, or Remote? On site
  3. What is the minimum experience required for this role? Molecular biology, biochemistry, first author publication.
  4. What is the minimum education required for this role? PhD
  5. How long are they expected to stay in this role? Project based
  6. What is the salary range? Competitive salary to Institute and NIH standards

TO APPLY
To apply for either position, email (1) CV; (2) cover letter that states research interests and goals; (3) the name of at least three references; to hanzhi.luo@fccc.edu

ABOUT THE TRAINING ENVIRONMENT
As one of the four original cancer centers to receive comprehensive designation from the National Cancer Institute, Fox Chase Cancer Center has been at the forefront of cancer research for almost 90 years. We are home to excellent research facilities, top clinicians and scientists, and outstanding patient care. Our singular focus on cancer, which couples discovery science with state of the art clinical care and population health, remains the foundation of our work.

The scientist training programs at Fox Chase Cancer Center provide professional development opportunities in four core areas identified as crucial for successful careers in science, research, and health care including communication, leadership, teaching, and mentorship. Upon joining the program, graduate students and postdocs develop individual development plans to help guide their growth. Training throughout the year is supplemented with free professional development opportunities, including a robust ‘How To’ series, writing courses, networking, mentorship, and teaching opportunities, a trainee-led seminar series, a trainee-led annual Research Conference, and more. Postdocs at Fox Chase Cancer Center are supported by the Temple University Postdoc Association and the Office of Academic Affairs at Fox Chase, and are compensated with competitive pay and benefits.

In addition to the robust training program, scientists at Fox Chase Cancer Center benefit from being part of the rich scientific and biotech environment in the Philadelphia region. Many of our former trainees are now employees (and contacts) at nearby institutions and companies, including The Wistar Institute, Merck, GSK, AACR, and numerous others.

Read More

The Ohio State University Comprehensive Cancer Center – T32 Post-Doctoral Fellow

Location: Columbus, Ohio

Application Deadline: Rolling

Seeking postdocs for T32: The OSUCCC – James has open postdoctoral positions in the T32 Cancer Prevention and Control Research Training Program, led by Dr. Peter Shields and Dr. Chyke Doubeni. This NIH-funded program provides multidisciplinary training across the full spectrum of cancer prevention and control, including cancer risk, epidemiology (such as tobacco-related research), and health outcomes. The goal of the program is to prepare the next generation of independent cancer researchers through mentorship, collaborative research, and career development opportunities. Trainees will benefit from a strong research infrastructure, diverse expertise, and a collaborative scientific environment. Eligible applicants must hold an MD, DO, DVM, DDS, or PhD. Physician-scientists currently in or having completed clinical training are encouraged to apply. To be considered, please submit a current CV, cover letter, one-page career statement, three letters of reference, and one representative publication to Kelly Wolfe at kelly.wolfe@osumc.edu

Read More

Rutgers University – Postdoctoral Position

Location: New Brunswick, New Jersey

An NIH-funded postdoctoral position is immediately available in the laboratory of Dr. Wei-Xing Zong at Rutgers University to study cancer cell metabolism and newly identified tumor suppressor genes. This position offers an excellent opportunity for rigorous training in cancer metabolism, cell growth signaling, and mouse models. The successful candidate will work in a collaborative environment with the goal of publishing high-impact research and developing an independent scientific career. Ph.D. in molecular biology, cell biology, biochemistry, or a related field with strong motivation, creativity, and commitment to scientific research. NIH-scale salary and comprehensive benefits will be provided.


Interested applicants please include curriculum vitae (CV) and names and contact information for three references to: Dr. Wei-Xing Zong (zongwx@pharmacy.rutgers.edu)
Lab website: https://sites.rutgers.edu/wei-xing-zong/

Read More

Van Andel Institute – Postdoc Preview

Location: Grand Rapids, Michigan
Application Deadline: 2/24/25

Are you a senior graduate student exploring your postdoc options? VAI Postdoc Preview provides selected applicants the opportunity to visit Van Andel Institute to learn about our postdoctoral training opportunities, meet one-on-one with our internationally recognized faculty and explore our extensive scientific resources, including our state-of-the-art Core Technologies and Services. VAI offers two Postdoc Preview events each year—one in the spring and one in the fall. There is no cost to attend. VAI provides transportation, lodging and meals for all selected applicants. We also are pleased to offer family care grants for those caring for children or other family members.

This application is for VAI’s Spring Postdoc Preview event on May 1 through May 3, 2025. Applications are due by February 24, 2025.

Eligibility
Applicants must be current graduate students at U.S. institutions who anticipate beginning a postdoctoral fellowship within the next year. Individuals who identify as members of underrepresented groups are strongly encouraged to apply. Preference will be given to applicants who are eligible for VAI’s NCI T32-funded Cancer Epigenetics Training Program and VAI’s Inspire Fellowship.Prior to starting the online application, please compile a list of VAI faculty members whose research interests you, along with your curriculum vitae.

About postdoctoral training at VAI
VAI labs conduct world-class biomedical research in cancer epigenetics, neurodegeneration, metabolism, cell biology and structural biology — all supported by outstanding Core Technologies and Services. Postdocs are a crucial part of VAI, so they receive highly competitive salaries, which start at $70,000 per year. VAI also offers postdocs comprehensive benefits, including low-cost health insurance for self and family, paid parental leave, and much more.

We offer numerous fully funded postdoctoral positions across our areas of focus. Learn more about postdoctoral training opportunities at VAI here. In addition, we have two internal fellowship programs: a National Cancer Institute T32-funded Cancer Epigenetics Training (CET) program, and the Inspire Fellowship program for postdocs who identify as underrepresented minorities. Please note that attending Postdoc Preview does not guarantee you a fellowship or a postdoc position at VAI; we encourage you to also apply to one or more of our open postdoc positions and fellowship opportunities (see FAQ tab on the VAI Postdoc Preview webpage for more information).

Questions? Please contact Dr. Erica Gobrogge, program director of VAI’s Office of Postdoctoral Affairs, at opa@vai.org.

About Van Andel Institute
Established in Grand Rapids, Michigan, in 1996 by the Van Andel family, VAI is now home to nearly 500 scientists, educators and support staff, who work with national and international collaborators to foster discovery. The Institute’s scientists study the origins of cancer, Parkinson’s and other diseases and translate their findings into breakthrough prevention and treatment strategies. Our educators develop inquiry-based approaches for K–12 education to help students and teachers prepare the next generation of problem-solvers, while our Graduate School offers a rigorous, research-intensive Ph.D. program in molecular and cellular biology.

About Grand Rapids, MI
Van Andel Institute is in downtown Grand Rapids, Michigan in the center of the Medical Mile. A remarkable combination of a cosmopolitan atmosphere and small-town warmth, Grand Rapids is known for its philanthropic and sustainability-driven community. It’s fun affordable and family-friendly. Located on the banks of the Grand River, Grand Rapids offers all the big-city excitement you’d expect from a million-resident metropolis, featuring hundreds of restaurants and nightspots, theaters, museums, sports and concerts. The safe and clean downtown is surrounded by an eclectic mix of walkable neighborhoods and natural areas.

FLYER

Read More

Winship Cancer Institute of Emory University – Postdoctoral Opportunities in Cancer Research – Recruitment Event 2025

Location – Atlanta, Georgia
Deadline Date: January 10, 2025 EXTENDED to midnight on January 31

Postdoc recruitment event at Emory this Spring! Come check out the opportunities in cancer research at the Winship Cancer Institute! See FLYER for details.

Read More

Wake Forest University School of Medicine – Postbaccalaureate Fellows

Location: Winston-Salem, North Carolina
Application Deadline Date: February 2025

We are excited to share with you information for an exciting a new postbaccalaureate program in the Department of Cancer Biology (https://school.wakehealth.edu/departments/cancer-biology) at the Wake Forest University School of Medicine. The program called Wake PREP2PhD is intended for those who will graduate in Spring 2025, or who recently graduated, and who want to gain valuable research experience in preparation for entry into a PhD program. Wake PREP2PhD is intending to target students who are historically underrepresented in science, including those from an economically disadvantaged background. 4 fellows will be recruited.

Wake PREP2PhD is a 2-year paid program (starting at $38K/year) where you will work full time in the laboratory doing cancer research, while also receiving important scientific and professional development such as scientific communication, application assistance, peer and professional networking, and more. The selected scholars will earn a stipend, be eligible for healthcare coverage, be provided a laptop (if necessary), and be eligible for financial moving assistance, in addition to rigorous scientific training.

Disease areas in the Department of Cancer Biology cover breast, prostate, lung, brain, leukemia, and other cancers with research topics covering genomics, signaling, therapeutic development, immuno-oncology, microbiome, and metabolism, among other topics.

If you are interested or have questions, please contact the Program Administrator, Kelly McNeal, and Program Director, Dr. Steven Kridel directly at kemcneal@wakehealth.edu and skridel@wakehealth.edu, respectively. The program application can be accessed at https://redcap.link/Prep2PhD or using the QR code on the attached flyer:

Wake_PREP2PhD_flyer.pdf

Read More

The Philadelphia Postdoc Preview

Location: Philadelphia, Pennsylvania
Held on Tuesday February 11, 2025

Join us to learn about postdoctoral training opportunities in Philadelphia!
The Philadelphia Postdoc Preview event is a collaborative effort to raise awareness about the numerous postdoctoral training opportunities at 8 research institutions across Philadelphia including The Children’s Hospital of Philadelphia, The Drexel University College of Medicine, Fox Chase Cancer Center – Temple Health, Lewis Katz School of Medicine – Temple Health, Monell Chemical Senses Center, Thomas Jefferson University, University of Pennsylvania Biomedical Postdoctoral Programs, and The Wistar Institute.

The next Philadelphia Postdoc Preview will be held on Tuesday February 11, 2025. During the Preview, participants will learn about:
-The various Postdoctoral training programs at participating research institutions
-What to consider when choosing where to train
-How to apply to a postdoc
-What it is like to live and work in Philadelphia?

The goal of the Preview event is to raise awareness of the robust training opportunities in the Philadelphia area. Whether you are interested in studying basic, translational, or clinical research in human or model systems, Philadelphia has lots of options for those interested in expanding their research expertise, developing professional skills needed in today’s job market, and growing a network of engaged and successful colleagues.

The target audience for the Preview event includes senior Ph.D. students (who have passed their qualifying exam or are post-candidacy by the time of the event), recent Ph.D. graduates, or early-career postdoc scholars in science, technology, engineering, math, and medical fields. Postdoctoral opportunities at the participating institutions include basic, translational, and clinical research. Information on clinical residencies and fellowships will NOT be presented.

There is no citizenship requirement to register. We are seeking domestic and international candidates alike!

For more information, go to: https://www.philadelphiapostdoc.com/
FLYER

Read More

University of Minnesota Masonic Cancer Center: Postdoctoral Fellows

Job location: Minneapolis, Minnesota
Application Deadline Date: OPEN

Postdoctoral positions in the Lange Lab: Seeking individuals driven to become future scientists and leaders in the field of hormones and cancer within academic basic and translational research, clinical, educational, regulatory, or other science-related careers.

My research team is focused on the role of steroid hormone receptors (SRs) in hormone-driven cancers. Estrogen receptor (ER) and progesterone receptors (PRs) are context-dependent transcription factors that are essential for development of the breast and reproductive tract. Altered sex hormone levels contribute to cancer risk in these tissues and drive metabolic and cell fate transitions associated with rapid tumor progression. The presence of abnormally activated ERs and imbalanced/activated PR isoforms in SR+ tumors can dramatically influence response to endocrine or other therapies. Our overarching research goal is to better understand how SR+ breast cancers and other hormone-influenced cancers of reproductive tissues escape endocrine (i.e. SR-blocking) or other molecular targeted therapies that primarily target proliferating cells. Strategies aimed at targeting metabolically active, but weakly proliferative or non-proliferative (G0) cancer stem or heterogeneous stem-like cell sub-populations as well as highly migratory dormant or quiescent cells (i.e. living as disseminated “active” G0 cells in the circulation or within distant “cancerized” tissue niches) would provide a powerful complement to existing therapeutic strategies. Novel signaling pathway biomarkers may inform new combination therapies.

Signal transduction is an essential role of SRs. Indeed, all SRs can rapidly activate cytoplasmic protein kinases and act as “growth factor sensors”. In this role, SRs are heavily phosphorylated by mitogenic protein kinases (MAPKs, AKT, CDKs) that are frequently elevated and activated in breast and reproductive tract cancers. Phosphorylation of SRs alters their binding partners and promoter selection and influences cancer cell fate/plasticity by regulating genes that specify proliferative, pro-survival, metabolic, and cancer stem cell programs via expression of both autocrine and paracrine factors. Similarly (i.e. via rapid signaling and phosphorylation events), the glucocorticoid receptor (GR) acts as a sensor for both host (i.e. hormonal) and cellular stress, in the form of local cytokines and/or hypoxic conditions within the tumor microenvironment. Identifying the required kinase and co-activator partners of phospho-SRs will enable the targeting of multiple signaling molecules in addition to SRs, which is predicted to halt cancer metastasis, prevent recurrence, and increase patient survival.

My lab has extensive experience developing and using human cancer cell lines and primary cells, genetically modified mouse models, and human tumor specimens. We have routinely developed new reagents and employed classical biochemistry and molecular biology techniques to study SR action and novel mechanisms of gene regulation that impact breast tumor development and progression, cancer stem cell biology, and endocrine therapy resistance. More recently, we have included significant focus on the development of early SR+ fallopian tube lesions that give rise to high grade serous ovarian cancer. We typically complement in vitro studies focused on the mechanisms of signaling inputs to SR-dependent regulation of transcription with the use of genetically modified mice or human patient derived xenograft (PDX) models maintained in mice.

Ongoing projects encompass the following research themes and their molecular mechanisms:

• ER? and PR isoform signaling cross talk in luminal breast cancer progression
• Ligand-independent actions of p-SRs and p-SR-containing complexes in breast cancer
• Cellular “stress” sensing by phospho-GR in triple negative breast cancer progression
• Novel HIF/GR-induced signaling pathways mediated by Breast Tumor Kinase/PTK6
• Fallopian tube transformation and early SR+ serous ovarian cancer progression
• Cell fate plasticity (cell cycle exit/entry into G0) and breast cancer stem cell biology
• Mechanisms of and biological role of cancer cell dormancy/quiescence and senescence
• SR and signaling pathway regulation of breast cancer stem cell populations and biology
• Inflammatory and tumor microenvironmental inputs to altered SR signaling in SR+ tumors
• Breast cancer metastatic cell dissemination as circulating tumor cell/stem cell clusters

SEND CV and list of 2-3 references to Dr. Carol A. Lange at lange047@umn.edu

PDF version

Read More